Exploratory Study to Estimate the Prophylactic Efficacy of Palivizumab in Healthy Adult Participants Inoculated With RSV

NCT04540627 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adult Participants

Interventions

DRUG: Palivizumab
DRUG: Placebo
OTHER: RSV-A Memphis 37b virus

Sponsor

mAbxience Research S.L.